LivaNova PLC (NASDAQ:LIVN)
| 55.67 Delayed Data As of Jan 26 |  -0.46 / -0.82%Today’s Change | 41.82 Today|||52-Week Range 88.00 | +0.23% Year-to-Date |
Latest LIVN News | Press Releases
No recent news for LivaNova PLC.
Today’s Trading
| Previous close | 56.13 |
| Today’s open | 55.39 |
| Day’s range | 55.28 - 55.95 |
| Volume | 11,332 |
| Average volume (3 months) | 430,306 |
| Market cap | $3.0B |
Data as of 4:00pm ET, 01/26/2023
Growth & Valuation
| Earnings growth (last year) | +62.39% |
| Earnings growth (this year) | +12.17% |
| Earnings growth (next 5 years) | +22.90% |
| Revenue growth (last year) | +10.82% |
| P/E ratio | NM |
| Price/Sales | 4.28 |
| Price/Book | 2.34 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IRTCiRhythm Technologies... | 0.00 | 0.00% |
| TNDMTandem Diabetes Care... | -0.55 | -1.38% |
| ---- | ||
| NVRONevro Corp | -1.42 | -3.75% |
Data as of 4:00pm ET, 01/26/2023
Financials
| Next reporting date | February 22, 2023 |
| EPS forecast (this quarter) | $0.73 |
| Annual revenue (last year) | $1.0B |
| Annual profit (last year) | -$135.8M |
| Net profit margin | -13.12% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters London, Greater London |
Forecasts
